Topic: Private Plan Drug Cost Forecast, OHIP+ and More
Innovative Medicines will share a report that includes an analysis that projects forward actual private drug plan drug costs for the coming year. OHIP+ will likely be changed this month to make private payers first payers again. We’ll share any updates on this and other initiatives that are going to shape 2019. See what’s coming and why being aware is not being afraid.
Joe Farago – Innovative Medicines
Dave Patriarche – Mainstay / CGIB
Sponsored By: Maximum Benefit
Cost: $75 Members & Guests, $175 Non-members (includes HST #815938600)
THIS EVENT PROVIDES HOT BREAKFAST